Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection

Journal of Immunology

Volumn 179, Issue 3, 2007, Pages 1842-1854

  Domínguez Punaro, María C ^a   Segura, Mariela ^c   Plante, Marie Michèle ^b   Lacouture, Sonia ^a   Rivest, Serge ^b   Gottschalk, Marcelo ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CXCL1 CHEMOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CHEMOKINE; CYTOKINE; I KAPPA B; I KAPPA B BETA; TLR2 PROTEIN, MOUSE; TLR3 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INNATE IMMUNITY; MENINGITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; SWINE; ANIMAL; BACTERIAL MENINGITIS; BIOSYNTHESIS; BRAIN; DEMYELINATING DISEASE; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANIMALS; ANTIGENS, CD14; BRAIN; CHEMOKINES; CYTOKINES; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FEMALE; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; MENINGITIS, BACTERIAL; MICE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS; SWINE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4;

EID: 34548619488     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.3.1842     Document Type: Article

References (69)

1. Higgins, R., and M. Gottschalk. 2005. Diseases of swine. In Streptococcal diseases, 9 Ed. B. Straw, J. J. Zimmerman, S. D'Allaire, and D. J. Taylor, eds. Iowa State University Press, Ames, pp. 769-783.
2. Dupas, D., M. Vignon, and C. Geraut. 1992. Streptococcus suis meningitis: a severe noncompensated occupational disease. J. Occup. Med. 34: 1102-1105.
3. Madsen, L. W., B. Svensmark, K. Elvestad, B. Aalbaek, and H. E. Jensen. 2002. Streptococcus suis serotype 2 infection in pigs: new diagnostic and pathogenetic aspects. J. Comp. Pathol. 126: 57-65.
4. Yen, M. Y., Y. C. Liu, J. H. Wang, Y. S. Chen, Y. H. Wang, and D. L. Cheng. 1994. Streptococcus suis meningitis complicated with permanent perceptive deafness: report of a case. J. Formos. Med. Assoc. 93: 349-351.
5. Ye, C., X. Zhu, H. Jing, H. Du, M. Segura, H. Zheng, B. Kan, L. Wang, X. Bai, Y. Zhou, et al. 2006. Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg. Infect. Dis. 12: 1203-1208.
6. Segura, M., and M. Gottschalk. 2004. Extracellular virulence factors of streptococci associated with animal diseases. Front. Biosci. 9: 1157-1188.
7. Baums, C. G., U. Kaim, M. Fulde, G. Ramachandran, R. Goethe, and P. Valentin-Weigand. 2006. Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis. Infect. Immun. 74: 6154-6162.
8. Madsen, L. W., H. Bak, B. Nielsen, H. E. Jensen, B. Aalbaek, and J. H. Riising. 2002. Bacterial colonization and invasion in pigs experimentally exposed to Streptococcus suis serotype 2 in aerosol. J. Vet. Med. B. 49: 211-215.
9. Gottschalk, M., and M. Segura. 2000. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet. Microbiol. 76: 259-272.
10. Tenenbaum, T., R. Adam, I. Eggelnpohler, D. Malaton, A. Seibt, G. E. Novotny, H. J. Galla, and H. Schroten. 2005. Strain-dependent disruption of blood-cerebrospinal fluid barrier by Streptoccocus suis in vitro. FEMS Immunol. Med. Microbiol. 44: 25-34.
11. Rubin, L. L., and J. M. Staddon. 1999. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22: 11-28.
12. Huang, S. H., M. F. Stins, and K. S. Kim. 2000. Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis. Microbes Infect. 2: 1237-1244.
13. Koedel, U., W. M. Scheld, and H. W. Pfister. 2002. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect. Dis. 2: 721-736.
14. Jobin, M. C., J. Fortin, P. J. Willson, M. Gottschalk, and D. Grenier. 2005. Acquisition of plasmin activity and induction of arachidonic acid release by Streptococcus suis in contact with human brain microvascular endothelial cells. FEMS Microb. Lett. 252: 105-111.
15. Vadeboncoeur, N., M. Segura, M. Doré, and M. Gottschalk. 2003. Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol. Med. Microbiol. 35: 49-58.
16. 2 and matrix metalloproteinase 9 production by human macrophage-like cells: synergistic effect of capsular material and cell wall from Streptococcus suis. Microb. Pathog. 40: 29-34.
17. Segura, M., J. Stankova, and M. Gottschalk. 1999. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor α and interleukin-6 production by murine macrophages. Infect. Immun. 67: 4646-4654.
18. Segura, M., N. Vadeboncoeur, and M. Gottschalk. 2002. CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin. Exp. Immunol. 127: 243-254.
19. Segura, M., G. Vanier, D. Al-Numani, S. Lacouture, M. Olivier, and M. Gottschalk. 2006. Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol. Med. Microbiol. 47: 92-106.
20. Al-Numani, D., M. Segura, M. Doré, and M. Gottschalk. 2003. Up-regulation of ICAM-1, CD11a/CD18 and CD11c/CD18 on human THP-1 monocytes stimulated by Streptococcus suis serotype 2. Clin. Exp. Immunol. 133: 67-77.
21. Graveline, R., M. Segura, D. Radzioch, and M. Gottschalk. 2007. TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness Int. Immunol. 19: 375-389.
22. Nguyen, M. D., J. P. Julien, and S. Rivest. 2002. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3: 216-227.
23. Olson, J. K., and S. D. Miller. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173: 3916-3924.
24. Jack, C. S., N. Arbour, J. Manusow, V. Montgrain, M. Blai, E. McCrea, A. Shapiro, and J. P. Antel. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175: 4320-4330.
25. Vanier, G., M. Segura, P. Friedl, S. Lacouture, and M. Gottschalk. 2004. Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infect. Immun. 72: 1441-1449.
26. Higgins, R., and M. Gottschalk. 1990. An update on Streptococcus suis identification. J. Vet. Diagn. Invest. 2: 249-252.
27. Laflamme, N., G. Soucy, and S. Rivest. 2001. Circulating cell wall components derived from Gram-negative, not Gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J. Neurochem. 79: 648-657.
28. Laflamme, N., H. Echchannaoui, R. Landmann, and S. Rivest. 2003. Cooperation between Toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from Gram-negative and Gram-positive bacteria. Eur. J. Immunol. 33: 1127-1138.
29. Glezer, I., A. Lapointe, and S. Rivest. 2006. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 20: 750-752.
30. Paxinos, G., and K. B. J. Franklin. 2001. The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
31. Vallieres, L., and S. Rivest. 1999. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 140: 3890-3903.
32. Babcock, A. A., W. A. Kuziel, S. Rivest, and T. Owens. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 23: 7922-7930.
33. Song, M., and J. A. Kellum. 2005. Interleukin-6. Crit. Care Med. 33(Suppl.): S463-S465.
34. Dofferhoff, A. S., E. Vellenga, P. C. Limburg, A. van Zanten, P. O. Mulder, and J. Weits. 1991. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature. Neth. J. Med. 39: 45-62.
35. Ebong, S., D. Call, J. Nemzek, G. Bolgos, D. Newcomb, and D. Remick. 1999. Immunopathologic alterations in murine models of sepsis of increasing severity. Infect. Immun. 67: 6603-6610.
36. Teti, G., G. Mancuso, and F. Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor α antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61: 227-235.
37. Abdi, K. 2002. IL-12: the role of p40 versus p75. Scand. J. Immunol. 56: 1-11.
38. Allan, S. M., P. J. Tyrrell, and N. J. Rothwell. 2005. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5: 629-640.
39. Ley, C. 2003. Arrest cytokines. Microcirculation 10: 289-295.
40. Bagglioni, M. 2001. Chemokines in pathology and medicine. J. Intern. Med. 250: 91-104.
41. Schall, T. J., K. Bacon, K. J. Toy, and D. V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671.
42. Sergerie, Y., G. Boivin, D. Gosselin, and S. Rivest. 2007. Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. J. Infect. Dis. 195: 817-825.
43. Brochu, S., M. Olivier, and S. Rivest. 1999. Neuronal activity and transcription of proinflammatory cytokines, IκBα, and iNOS in the mouse brain during acute endotoxemia and chronic infection with Trypanosoma brucei brucei. J. Neurosci. Res. 57: 801-816.
44. Greer, J. M., and M. B. Less. 2002. Myelin proteolipid protein- the first 50 years. Int. J. Biochem. Cell. Biol. 34: 211-215.
45. Koedel, U., and H. W. Pfister. 1999. Models of experimental bacterial meningitis: role and limitations. Infect. Dis. Clin. North Am. 13: 549-577.
46. Gerber, J., G. Raivich, A. Wellmer, C. Noeske, T. Kunst, W. Bruck, and R. Nau. 2001. A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathol. 101: 499-508.
47. Chiavolini, D., S. Tripodi, R. Parigi, M. R. Ogglioni, E. Blasi, M. Cintorino, G. Pozzi, and S. Ricci. 2004. Method for inducing experimental pneumococcal meningitis in outbred mice. BMC Microbiol. 4: 36-45.
48. Mancuso, G., A. Midiri, C. Beninati, C. Biondo, R. Galbo, S. Akira, P. Henneke, D. Golenbock, and G. Teti. 2004. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J. Immunol. 172: 6324-6329.
49. Norrby-Teglund, A., K. Pauksens, M. Norgren, and S. E. Holm. 1995. Correlation between serum TNF α and IL6 levels and severity of group A streptococcal infections. Scand. J. Infect. Dis. 27: 125-130.
50. Goldmann, O., G. S. Chhatwal, and E. Medina. 2005. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J. Infect. Dis. 191: 1280-1286.
51. Raeder, R. H., L. Barker-Merrill, T. Lester, D. Boyle, and D. W. Metzger. 2000. A pivotal role for interferon-γ in protection against group A streptococcal skin infection. J. Infect. Dis. 181: 639-645.
52. Dinarello, C. A. 2005. Interleukin-1β. Crit. Care Med. 33: S460-S462.
53. Moller, A. S., A. Bjerre, B. Brusletto, G. B. Joo, P. Brandtzaeg, and P. Kierulf. 2005. Chemokine patterns in meningococcal disease. J. Infect. Dis. 191: 768-775.
54. Fowler, M. I., R. O. Weller, J. E. Heckels, and M. Christodoulides. 2004. Different meningitis-causing bacteria induce distinct inflammatory responses on interaction with cells of the human meninges. Cell Microbiol. 6: 555-567.
55. Koedel, U., A. Bernatowicz, K. Frei, A. Fontana, and H. W. Pfister. 1996. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J. Immunol. 157: 5185-5191.
56. Koedel, U., B. Angele, T. Rupprecht, H. Wagner, A. Roggenkamp, H. W. Pfister, and C. J. Kirschning. 2003. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170: 438-444.
57. Echchannaoui, H., K. Frei, C. Schnell, S. L. Leib, W. Zimmerli, and R. Landmann. 2002. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 186: 798-806.
58. Bottcher, T., M. v. Mering, S. Ebert, U. Mayding-Lamade, U. Kuhnt, J. Gerber, and R. Nau. 2003. Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections. Neurosci. Lett. 344: 17-20.
59. Letiembre, M., H. Echchannaoui, P. Bachmann, F. Ferracin, C. Nieto, M. Espinosa, and R. Landmann. 2005. Toll-like receptor 2 deficiency delays pneumococcal phagocytosis and impairs oxidative killing by granulocytes. Infect. Immun. 73: 8397-8401.
60. Malley, R., P. Henneke, S. C. Morse, M. J. Cieslewicz, M. Lipsitch, C. M. Thompson, E. Kurt-Jones, J. C. Paten, M. R. Wessels, and D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 100: 1966-1971.
61. Kim, Y. S., J. Honkaniemi, F. R. Sharp, and M. G. Tauber. 2004. Expression of proinflammatory cytokines tumor necrosis factor-α and interleukin-1β in the brain during experimental group B streptococcal meningitis. Mol. Brain Res. 128: 95-102.
62. Laflamme, N., and S. Rivest. 2001. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 15: 155-163.
63. Rivest, S. 2003. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 17: 13-19.
64. Constantin, D., A. Cordenier, K. Robinson, D. A. Ala'Aldeen, and S. Murphy. 2004. Neisseria meningitidis-induced death of cerebrovascular endothelium: mechanisms triggering transcriptional activation of inducible nitric oxide synthase. J. Neurochem. 89: 1166-1174.
65. Jermann, H., C. Hii, G. Hodge, and A. Ferrante. 2001. Synthesis and surface expression of CD14 by human endothelial cells. Infect. Immun. 69: 479-485.
66. Beekhuizen, H., I. Blokland, A. J. Corsel van Tilburg, F. Koning, and R. van Furth. 1991. CD14 contributes to adherence of human monoctyes to cytokine-stimulated endothelial cells. J. Immunol. 147: 3761-3767.
67. Singh, A. K., and Y. Jiang. 2004. How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 201: 197-207.
68. Glod, J., D. Kobiler, M. Noel, R. Koneru, S. Lehrer, D. Medina, D. Maric, and H. A. Fine. 2006. Monocytes form a vascular barrier and participate in vessel repair after brain injury. Blood. 107: 940-946.
69. Guillemin, G. J., and B. J. Brew. 2004. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukocyte Biol. 75: 388-397.